“Why do I have to keep updating the stakeholders? I just sent them a progress report a few days ago and nothing has changed…,” a question project managers ask themselves all too often. Obviously, the stakeholders have invested a significant portion of money into the development of the new drug and he/she is always in […]
The next big market share grab will go to the organization that figures out how to reduce the number of resubmissions to the Food and Drug Administration (FDA) , and thus reduce the time it takes to get a product to market. When you have a project on a large scale such as the development […]
There have been volumes said about the benefits and woes of centralized decision-making. An equal amount has been written touting the benefits and woes of decentralized decision-making. I think it is safe to say that in different situations one decision-making approach is better than another. I would also maintain that there is space for both […]
What? I’m not losing data! Actually you are. It is correct; you have not had a major IT system crash in years. And even if you did, systems are being backed up on a regular basis and are recoverable. And, it is true; you may have had issues with people storing data in the wrong […]
In spite of recent advances in science and technology, the next great innovation in drug research and development is not going to be a major breakthrough in cancer, HIV, or some other research. That is; an increase in sustained profits will not be as a result of introducing a new breakthrough drug on the market. […]
There are tremendous advantages from being on the same page. Think of a stringed quartet. If they are not all on the same page, the harmonies produced by their instruments will not exist and the audience will walk out. The same principle can be applied to the drug research process. If all participants are not […]